Daria and Sophie join the Dynamic42 lab team as permanent members
We are delighted to announce that after their Master studies Daria and Sophie will join our team permanently as research assistants.
Both Daria and Sophie studied at the Department of Pharmaceutical Biotechnology at the Ernst-Abbe University of Applied Sciences (EAH). Sophie focussed on the emulation of an inflammatory bowel disease (IBD) model in her Master thesis working in close cooperation with her supervisors Dr. Katja Graf and Tim Kaden. In this research project, a microphysiological intestinal model was leveraged as a platform to investigate the protective effects of probiotic lactic acid bacterium Lactobacillus rhamnosus GG on host tissue during inflammatory responses in IBD.
Daria’s Master thesis was about the immune-related side effects and the toxicity of therapeutic antibodies focus on liver cells. This study was conducted in close cooperation with her supervisors Anne-Kathrin Bothe and Dr. Martin Raasch from Dynamic42.
Both are particularly interest in developing innovative technology that recapitulates the human anatomy and physiology, allowing for more realistic disease modelling, underlying molecular mechanisms and potential therapy targets. Further, they have an invested interest to contribute to the reduction of animal experiment through the organ-on-a-chip platforms they develop.
Daria and Sophie first gained insights into the work at Dynamic42, through their degree program, as part of the module ‘In-vitro diagnostics’.
If you have questions about us or our programme for students and doctoral candidates, please get in touch!
Read more News:
Cancer, rheumatism, asthma: organ-on-chip models highly relevant for preclinical testing of therapeutic antibodies
Improving people’s lives with innovative technologies. This was the goal that Jena-based Dynamic42 had in mind 18 months ago when they launched a project – funded as part of the Sanofi iDEA-iTECH Award Program.
Joanna Nowacka joins Dynamic42 as Lead for Stem Cell Model Development
We are delighted to announce that Joanna Nowacka has joined Dynamic42 as Lead for Stem Cell Model Development.
Amélie Marie Paillereau joins Dynamic42 as Master Student funded by the Thuringia and European Social Fund Plus
We are excited to welcome Amélie Marie Paillereau to the Dynamic42 science team. Amélie started in April with us for a 12-month-long Master thesis, focusing on perfused breast and pancreatic cancer-on-chip models to study the impact of the tumor microenvironment on immune cell invasion.